Z-square

Company Overview

Snapshot

Founded in April 2013 by Asaf Shahmoon and Zeev Zalevsky, Z-square operates with 11–50 employees. The company has raised $10M across one funding round from two investors. In February 2019, Z-square secured funding from The Chartered Group.

Business overview

Z-square develops a proprietary multifunctional microendoscope designed for high-quality, minimally invasive imaging within a super-slim fiber. This technology platform provides comprehensive elements for imaging and treatment, including various energy and drug deliveries, irrigation, and tissue handling. The company's single-use endoscopes aim to eliminate cross-contamination risks associated with reusable endoscopes, thereby improving patient outcomes, generating systemic savings for healthcare providers, enhancing usability and diagnosis quality, and expanding access to endoscopic-assisted procedures. Z-square operates within the Health Tech & Life Sciences sector, focusing on medical devices, medical treatment, therapeutics, and diagnostics devices.

Strategic signal

In March 2020, Z-square was recognized as a Silver Winner of the 2020 Edison Awards. This accolade highlights the company's innovative contributions to medical technology, signaling industry validation and potential for broader market adoption of its microendoscope technology.

Company Intelligence Q&A

What is Z-square's core product?

Z-square develops a proprietary multifunctional microendoscope capable of high-quality, minimally invasive imaging within a super-slim fiber, offering elements for complete imaging and treatment.

When was Z-square founded and by whom?

Z-square was founded in April 2013 by co-founders Asaf Shahmoon and Zeev Zalevsky.

What significant recognition did Z-square receive in 2020?

In March 2020, Z-square was named a Silver Winner of the 2020 Edison Awards for its innovative microendoscope technology.

What problem does Z-square's technology aim to solve in healthcare?

Z-square's single-use endoscopes aim to eliminate cross-contamination risks from poorly sterilized reusable endoscopes, improving patient outcomes and providing systemic savings for healthcare providers.